Insider Shareholders with Direct Ownership of Impel Pharmaceuticals Inc (IMPL)
This section provides a comprehensive overview of the insiders with direct ownership of Impel Pharmaceuticals Inc (IMPL). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
IMPEL PHARMACEUTICALS INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Norwest Venture Partners Xiv, Lp
> 10% Shareholder |
3,077,198 | 0 | 3,077,198 $61,543 | 1 |
Apr 27, 2021
Added 21.14%
|
| 2,759,791 | 0 | 2,759,791 $55,195 | 1 |
Apr 27, 2021
Added 14.02%
|
|
|
John Hoekman
Chief Scientific Officer |
24,523 | 275 | 128,221 $2,564 | 3 |
Dec 22, 2021
Added 13.49%
|
|
Stephen B Shrewsbury
Chief Medical Officer |
97,990 | 0 | 97,990 $1,959 | 2 |
Mar 29, 2022
Added 20.07%
|
|
Adrian Adams
COB, CEO and President |
20,000 | 0 | 20,000 $400 | 1 |
Aug 18, 2021
Added 2.91%
|
|
H Stewart Parker
Director |
20,151 | 2,124 | 17,756 $355 | 2 |
Apr 27, 2021
Reduced 8.58%
|
|
John Harold Leaman
Chief Fin. & Business Officer |
10,571 | 3,627 | 6,944 $138 | 2 |
Dec 31, 2022
Reduced 34.31%
|
| 10,000 | 10,000 | 0 $0 | 2 |
Apr 05, 2024
Reduced 100.0%
|